ESTA
Establishment Labs Holdings Inc.·Healthcare
71.32
1.817%(−1.32)
Close PriceLast Updated: — ET
52W L: $33.3552W H: $83.31
ESTA NEWS
globenewswire.com
May 18
Route 92 Medical Announces Appointment of Raj Denhoy as Chief Financial Officer
WEST JORDAN, Utah, May 18, 2026 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the appointment of Raj Denhoy to the role of Chief Financial Officer (CFO) effective today. “Route 92 Medical has built a strong position in neurovascular intervention,” said Raj Denhoy, CFO at Route 92 Medical.
fool.com
May 11
ESTA Founder Sells $7.9M on Earnings Day — Here's Why that's Not the Story
This global medtech firm specializing in advanced implant solutions reported a notable insider sale amid a year of strong share performance.
seekingalpha.com
May 6
Establishment Labs Holdings Inc. (ESTA) Q1 2026 Earnings Call Transcript
Establishment Labs Holdings Inc. (ESTA) Q1 2026 Earnings Call Transcript
zacks.com
May 6
Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Tops Revenue Estimates
Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.4 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to a loss of $0.7 per share a year ago.
businesswire.com
May 6
Establishment Labs Reports First Quarter 2026 Financial Results
NEW YORK--(BUSINESS WIRE)---- $ESTA #Breast--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the first quarter ended March 31, 2026. First Quarter Highlights and Outlook (Unaudited) Revenue of $59.9 million, up 44.7% from Q1 2025, with guidance raised to $266.5 million to $268.5 million $19.6 million of Motiva sales in the United State.
businesswire.com
Apr 30
Establishment Labs® Refinances Credit Facility
NEW YORK--(BUSINESS WIRE)---- $ESTA #Breast--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced it has entered into a $300 million senior secured term loan facility with funds managed by Oaktree Capital Management, L.P. (“Oaktree”). The amended and restated facility refinances the company's existing debt and allows access to additional capital to support ongoi.
